LeanBio Therapeutics, Inc. has recently filed a Form D to announce an exempt offering of securities. This filing is significant as it indicates the company's intention to raise capital, which is essential for its ongoing and future projects in the biotechnology sector.
Background
LeanBio Therapeutics, Inc. is a biotechnology company focused on developing innovative therapeutic solutions. The company is incorporated in Delaware and has its business address in Brookline, Massachusetts. LeanBio is categorized under the SIC description related to biotechnology, although specific SIC details were not provided in the filing.
What the Filing Says
The Form D filing, dated October 22, 2026, indicates that LeanBio is pursuing an exempt offering of securities under items 06b and 4a5. The effectiveness date of this offering is also noted as October 22, 2026. However, specific details regarding the amount being raised or the type of securities offered were not disclosed.
Impact
This move may affect various stakeholders, including current investors, potential investors, and the broader biotechnology community. By securing additional funding, LeanBio can continue to develop its therapeutic solutions, which may impact its competitive positioning in the market.
What's Next
The filing does not say what happens next.
Company Information
LeanBio Therapeutics, Inc. is registered with the Central Index Key (CIK) number 0002160802 and has an Employer Identification Number (EIN) of 424054744. The company is incorporated in Delaware and has a fiscal year ending on December 31.
Contact Information
The mailing address for LeanBio Therapeutics is 931 Porterville Road, East Aurora, NY 14052. The business address is listed as 80 Park Street, Apt PH, Brookline, MA 02446, with a contact phone number of 716-655-7788.
Filing Details
This Form D filing was accepted on October 21, 2026, and indicates that there is one document associated with this filing. The effectiveness date aligns with the filing date, both set for October 22, 2026.
Regulatory Context
The filing references items 06b and 4a5, which pertain to the exemption from registration under the Securities Act of 1933. However, the filing does not provide details on the specific exemptions being claimed or the nature of the securities being offered.
Missing Information
While the filing provides essential details regarding the company's intent to raise capital, it does not disclose the specific amount of capital being sought or the types of securities being offered. Additionally, there is no information regarding the intended use of the proceeds from this offering.